
这个市场不值得进,已经是明显的高风险价格战市场。 近一年新品牌新发产品的盈利率只有5.88%,新品牌新发失败率高达92.86%,而且最近一批新品几乎全是亏损或未跑通,说明竞争是在加速恶化,不是在变好。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不值得进,且500,000 CNY只能勉强覆盖少数入场成本,但无法支撑长期品牌战。 当前可盈利新产品占比只有5.88%,市场可盈利产品占比也只有16.00%,而新品牌新发产品的非盈利率高达92.86%,说明这里不是正常增长市场,而是高失败率、强价格竞争的战场。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,属于明显的价格战高风险市场:样本里可识别盈利产品只有16%,新品盈利率只有5.88%,而且2025年到2026年新上架产品几乎都是亏损,说明新入场越来越难,不是增长型机会。对小品牌来说更不友好,可验证的小品牌成功案例几乎没有,反而是大量新品牌和新ASIN在烧钱后失败;对大品牌来说也不是好市场,除非愿意用很重的品牌和投放去硬砸。
这个市场不适合进入:已经明显进入价格战和过度拥挤状态,新品牌胜率低,小商家几乎没有不靠激进打法就成功的空间。 现有数据里,新产品盈利率只有7.14%,新品牌新上架产品未盈利率高达92.86%,而且市场难度被直接判定为高;更关键的是,只有一个新品牌 medicube 证明了能赚钱,但它靠的是品牌力+功能差异+高投入,不是普通小商家可复制的路径。
证据很直接:新上架产品里,只有 B0FPQGLYK9(medicube)赚钱,利润率14.1%,月销6000,月营收£99,540;其余可见新品牌样本几乎都在亏或未跑通,像 B0GXF2QJNY(Domality)-7.04%、B0GRMJDGFN(YijiaXingzhou)-7.21%、B0FJY5NRPR(SEMECOMER)-17.55%。 这不是“少量失败”,而是新品牌整体失血;同时,市场里能稳定赚钱的还包括老品牌 Supergoop! 的 B0DZ36BRDR(17.67%,月销50)和 e.l.f. 的 B0BSP3N82M(11.34%,月销300),说明利润主要被成熟品牌拿走,新品牌想进来要么靠强品牌力,要么靠更重的营销和创新投入。你自己的预算是 50万CNY,表面上够一单启动,但这类成功案例的核心并不只是首批铺货,而是后续品牌建设、内容投放、产品差异化和持续获客,普通小商家很难仅靠这笔钱跑出同样结果。
结论:大品牌只有在愿意重投品牌和创新时才有机会,小商家不建议进。 现在这个类目最像“高竞争低容错”市场:B0F9LBK53X、B0FGD3Q2XL 这类通用型三合一防晒/妆前/校色产品都失败了,说明“功能堆叠但没差异”已经不够;如果还要硬进,基本只能走高预算、强品牌、强投放路线,甚至带一点激进营销才有机会。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FPQGLYK9 | medicube | 2026-03-10 | Yes | £16.59 | 6000pcs | £99540.0 | 14.1% | £14035.14 |
![]() | B0BSP3N82M | e.l.f. | 2023-01-25 | Yes | £14.35 | 300pcs | £4305.0 | 11.34% | £488.19 |
![]() | B0DZ36BRDR | Supergoop! | 2025-03-03 | Yes | £14.02 | 50pcs | £701.0 | 17.67% | £123.87 |
![]() | B01H3EWCH4 | HEIMISH | 2016-07-13 | Yes | £16.26 | 50pcs | £813.0 | 10.77% | £87.57 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FPQGLYK9 | medicube | 2026-03-10 | Yes | £16.59 | 6000pcs | £99540.0 | 14.1% | £14035.14 |
结论很明确:这个市场不值得进入,已经接近/进入过度拥挤,且利润被压得很薄。 新品牌新上架产品的盈利率只有5.88%,整体可确认盈利产品仅16.00%,而新品牌新上架失败率高达92.86%,这已经不是“还有机会”的市场,而是明显的高风险价格战市场。
证据上,真正能跑通的样本极少:唯一清晰成功的新品牌案例是 medicube 的 B0FPQGLYK9,售价£16.59,月销6000件、月营收£99,540、利润率14.1%,早期投入约£144,915.75,其中广告就占£32,403.16;它靠的是品牌力 + 功能差异化 + 借旧款思路做升级,不是低预算就能复制的普通新品。相反,老品牌 e.l.f. 的 B0BSP3N82M 虽然是活跃老品、4527条评论、仍有11.34%利润,但它的新上架 B0G5NG2G6J 直接亏损;新品牌里像 Domality 的 B0GXF2QJNY 只有1条评论、售价£9.99、利润率-7.04%,说明低价切入并没有解决问题。按评论节奏看,2025年到2026年4月-5月集中出现大量失败新品,失败品牌包括 SeeHoo、YijiaXingzhou、Petansy、OKAQEE、Grospe、SEMECOMER、Domality 等;这说明市场在加速内卷,而不是在自然扩张。
给你的判断:大品牌也不该贸然进,小品牌更不适合硬冲。 大品牌若要进,至少要准备接近 medicube 这种级别的品牌投入与差异化能力,并且面对老牌 e.l.f. 这类已验证玩家;小品牌只有在能做出真正差异化、且有足够预算覆盖研发/品牌/认证的情况下才“可能”活下来,但不是一个值得推进的市场。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不适合进入,已经接近价格战区,而且新品牌成功率极低。 近一年新品牌新上架里,盈利只有1个、失败13个,成功率仅7.14%,远低于你要求的10%警戒线;同时最新时间段持续出现更多失败新品牌,说明竞争在加剧,不是在变容易。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| 2026 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 8 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |